A detailed history of Diversified Trust CO transactions in Veracyte, Inc. stock. As of the latest transaction made, Diversified Trust CO holds 28,060 shares of VCYT stock, worth $963,019. This represents 0.02% of its overall portfolio holdings.

Number of Shares
28,060
Previous 22,860 22.75%
Holding current value
$963,019
Previous $506,000 20.16%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$18.86 - $23.55 $98,072 - $122,460
5,200 Added 22.75%
28,060 $608,000
Q1 2024

Apr 18, 2024

BUY
$21.0 - $29.1 $169,050 - $234,255
8,050 Added 54.36%
22,860 $506,000
Q4 2023

Jan 08, 2024

BUY
$19.72 - $28.68 $11,339 - $16,491
575 Added 4.04%
14,810 $407,000
Q3 2023

Nov 17, 2023

BUY
$22.33 - $29.92 $63,082 - $84,524
2,825 Added 24.76%
14,235 $317,000
Q2 2023

Jul 18, 2023

SELL
$20.96 - $26.99 $1,572 - $2,024
-75 Reduced 0.65%
11,410 $290,000
Q1 2023

Apr 07, 2023

SELL
$20.58 - $27.89 $1,749 - $2,370
-85 Reduced 0.73%
11,485 $256,000
Q4 2022

Jan 17, 2023

SELL
$15.31 - $29.94 $10,410 - $20,359
-680 Reduced 5.55%
11,570 $275,000
Q3 2022

Oct 14, 2022

BUY
$16.58 - $27.9 $7,046 - $11,857
425 Added 3.59%
12,250 $203,000
Q2 2022

Jul 12, 2022

BUY
$15.45 - $29.52 $18,926 - $36,162
1,225 Added 11.56%
11,825 $235,000
Q1 2022

Apr 07, 2022

BUY
$21.94 - $42.51 $33,458 - $64,827
1,525 Added 16.8%
10,600 $292,000
Q4 2021

Jan 13, 2022

BUY
$36.09 - $53.79 $37,894 - $56,479
1,050 Added 13.08%
9,075 $374,000
Q3 2021

Jan 13, 2022

BUY
$35.62 - $52.97 $32,057 - $47,673
900 Added 12.63%
8,025 $373,000
Q2 2021

Jul 20, 2021

BUY
$32.94 - $56.62 $50,760 - $87,251
1,541 Added 27.6%
7,125 $285,000
Q1 2021

May 10, 2021

BUY
$44.47 - $81.38 $248,320 - $454,425
5,584 New
5,584 $300,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.46B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Diversified Trust CO Portfolio

Follow Diversified Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Diversified Trust CO with notifications on news.